the knowledge platform

aesthetics 101: beyond botox

a reality-based plan for aesthetics: costs, prescribing mechanics, indemnity, stock, licensing, and why “mobile clinics” create legal and clinical risk.

The aesthetics trap is thinking the course is the business. Training is the entry ticket. The business is: compliant prescribing, defensible consent, adverse event readiness, and unit economics (indemnity + stock + premises + marketing).

The prescribing partner trap (and why remote is collapsing)

If you rely on a prescribing partner for prescription-only medicines, your model must track regulator rules on in-person assessment. From 1 June 2025, NMC standards require face-to-face consultation before nurse/midwife prescribers issue prescriptions for non-surgical cosmetic medicines. If your model depended on remote prescribing, redesign it.

Cost stack you must budget (before you treat a single patient)

Core costs typically include: appropriate indemnity/insurance, clinical supplies and stock (including emergency meds), prescribing workflow (if not prescribing yourself), premises costs, consent/documentation systems, waste/sharps disposal, and marketing acquisition.